May 15, 2026 11:07AM
Mar 6, 2026 06:15PM
Mar 6, 2026 06:15PM
Jan 27, 2026 08:00AM
Jan 27, 2026 08:00AM
Jan 21, 2026 07:01AM
Jan 21, 2026 07:00AM Lisata Therapeutics Enters Into Term Sheet to be Acquired by Kuva Labs for $4.00 Per Share in an All-Cash Tender Offer
Jan 22, 2025 08:00AM
Jan 21, 2025 08:14AM
May 9, 2024 04:05PM
Feb 29, 2024 04:05PM
Dec 12, 2023 08:00AM
Nov 2, 2023 04:05PM
Sep 6, 2023 08:00AM Lisata Therapeutics (LSTA) Announces Outcome of Interim Futility Analysis for its Phase 2b ASCEND Trial
Sep 6, 2023 08:00AM
Aug 14, 2023 04:05PM
Aug 14, 2023 04:05PM
May 24, 2023 08:00AM
May 9, 2023 04:05PM
May 9, 2023 04:05PM
Apr 20, 2023 08:30AM Lisata Therapeutics Receives $2.2 Million of Non-Dilutive Capital Through New Jersey Technology Business Tax Certificate Transfer Program
Apr 20, 2023 08:30AM
Apr 18, 2023 08:30AM
Apr 18, 2023 08:30AM
Mar 30, 2023 04:05PM
Mar 30, 2023 04:05PM
Nov 10, 2022 04:05PM
Nov 10, 2022 04:05PM Lisata Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
Sep 29, 2022 08:00AM
Sep 29, 2022 08:00AM
Sep 15, 2022 09:15AM

1,155,000 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All